|
GTF3C3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.786100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.340100E-03 |
| Normal-vs-Stage2 |
1.319700E-03 |
| Normal-vs-Stage3 |
6.11609999999763E-05 |
| Normal-vs-Stage4 |
4.982700E-04 |
| Stage1-vs-Stage2 |
2.923800E-01 |
| Stage1-vs-Stage3 |
7.842000E-02 |
| Stage1-vs-Stage4 |
2.383000E-01 |
| Stage2-vs-Stage3 |
8.200600E-01 |
| Stage2-vs-Stage4 |
9.405200E-01 |
| Stage3-vs-Stage4 |
8.792400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.176100E-04 |
| Normal-vs-AfricanAmerican |
2.057200E-01 |
| Normal-vs-Asian |
1.436110E-02 |
| Caucasian-vs-AfricanAmerican |
2.751800E-01 |
| Caucasian-vs-Asian |
6.959400E-01 |
| AfricanAmerican-vs-Asian |
4.789800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.76520000000036E-05 |
| Normal-vs-Female |
1.315640E-03 |
| Male-vs-Female |
2.284600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.263600E-02 |
| Normal-vs-Age(41-60Yrs) |
9.66019999999457E-05 |
| Normal-vs-Age(61-80Yrs) |
2.352700E-04 |
| Normal-vs-Age(81-100Yrs) |
2.669700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.345800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.080430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.616800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.444000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.568400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.790200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.513800E-01 |
| Classical-VS-Follicular |
2.724400E-02 |
| Classical-VS-Other |
2.360600E-01 |
| Classical-VS-Normal |
5.400100E-03 |
| Tall-VS-Follicular |
6.487400E-01 |
| Tall-VS-Other |
4.658000E-01 |
| Tall-VS-Normal |
5.619700E-03 |
| Follicular-VS-Other |
7.191000E-01 |
| Follicular-VS-Normal |
3.425300E-04 |
| Other-VS-Normal |
2.208200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.96680000000327E-05 |
| Normal-vs-N1 |
1.235200E-03 |
| N0-vs-N1 |
8.923200E-01 |
|
|
